Taken together, these observations reveal a pattern of reduced GPI-anchored protein release in CSF of patients with ALS, correlating with the abnormal intracellular accumulation of GDE2 in ALS patient postmortem samples. Here, GDPD5 is linked to amyotrophic lateral sclerosis.